In a cohort of suspected OSA patients, those with elevated ICAM-1 levels (>816 ng/mL) were significantly more likely to experience a cardiovascular event within 8 years following polysomnography [75]. The gene discussed is ICAM1; the disease is obstructive sleep apnea syndrome.